Prof. Abass Alavi
University of Pennsylvania, USA
1987 Professor of Psychiatry, University of Pennsylvania, USA
1982 Professor of Neurology, University of Pennsylvania, USA
1977 Associate Professor of Radiology, University of Pennsylvania, USA
Abass Alavi. (2011) “Molecular Imaging with PET”, “The
Critical Role of PET/CT in the Management of Patients with Cancer”, “The
Evolving Role of PET Imaging in Assessing Infection and Inflammation”, “Current
and Future Applications of PET in Neuro-Psychiatric Disorders”, PET/CT Cairo
Symposium, Cairo, Egypt.
Abass Alavi. (2010) Inaugural Speaker, CV Imaging Working
Group of the Penn Cardiovascular Institute, Penn CVI Cardiology/Radiology
seminar series, Philadelphia, PA.
Abass Alavi. (2010) “Emerging Role of Molecular Imaging
with PET in the Day to Day practice of Medicine”, Grand Rounds, Radiologic
Society of New Jersey, Robert Wood Johnson University Hospital,
University of Medicine and Dentistry of New Jersey, New Brunswick, NJ.
Abass Alavi. (2010) “Emerging Role of PET and PET-CT in
Assessing Musculoskeletal Disorders” Biomedical Engineering Graduate Students
Seminar”, Department of Orthopaedic Surgery & Rehabilitation Medicine, SUNY
Downstate Medical Center, Brooklyn, New York.
Abass Alavi. (2010) Panel Member, Scientific Review
Panel, R 21 applications, Clinical Studies of Bisphosphonate Therapy and
Osteonecrosis of the Jaw (R21). National Institute of Dental and Craniofacial
Abass Alavi. (2010) “Emerging Role of Hybrid Imaging
for Optimal Assessment of Molecular Alterations in Neuropsychiatric Disorders
and Its Implications for Individualized Treatments in the Future”, American
Society of Functional Neuroradiology, Vic Haughton Honorary Lecture, Wynn
Encore, Las Vegas.
Abass Alavi. (2010) “Molecular Imaging with PET, A
Revolution in Medicine”, ”Clinical Applications of PET in Lymphoma and
Pediatrics”, ”Emerging Role of PET in Assessing and monitoring Patients with
Suspected and Proven infection and inflammation”, ”Critical Role of PET in the
Management of patients with Central Nervous System Disorders” Nuclear Medicine
Section, Department of Medical Imaging, King Fahad Hospital, Riyadh, Kingdom of
Abass Alavi. (2010) “Emerging Role of PET and PET-CT in the
Day to Day Practice of Medicine”, Grand Rounds, Depart. of Internal Medicine,
Cleveland Clinic, Cleveland, OH.
Abass Alavi. (2010) “Novel Quantitative Techniques for
Defining Tumor Biology; a New Paradigm in Cancer Research”, Department of
Nuclear Medicine Research Conference, Cleveland Clinic Taussig Cancer Center,
Abass Alavi. (2010) “FDG-PET: A brief history to
current perspectives in oncologic imaging”, Grand Rounds, Department of Nuclear
Medicine, Cleveland Clinic Taussig Cancer Center, Cleveland, OH.
Abass Alavi. (2010) Scientific Review Panel, Nutrition
Obesity Research Centers (P30) applications, National Institute of Diabetes and
Digestive and Kidney Diseases, National Institutes of Health, Washington, DC.
Abass Alavi. (2010) Member, Scientific Review Panel,
Nanotechnology R25T and K99/R00 Applications for National Cancer Institute,
National Institutes of Health, Rockville, MD.
Abass Alavi. (2010) “Revolutionary Impact of Molecular
Imaging with PET on Research and the Day to Day Practice of Medicine”,
Dermatology Research Seminar Series, Department of Dermatology School of
Medicine, University of Pennsylvania, Phila., PA.
Abass Alavi. (2010) “18F-Fluorodeoxyglucose-Positron
Emission Tomography for the detection of infections and aseptic inflammatory
disorders”, CASE Seminars of the Food and Drug Administration, Division of
Antimicrobial and Ophthalmology Products, Center for Drug Evaluation and
Research, FDA White Oak campus, Silver Springs, MD.
Abass Alavi. (2010) Medical Education Program, Genzyme,
Inc., Cambridge, MA.
Abass Alavi. (2010) Application of Biomarkers and Imaging
to Early Phase Studies with an Anti-LOXL2 Antibody, Arresto BioSciences, Palo